CLB
Core Laboratories NV
Core Laboratories NV historical holders
total: 9
Disciplined Growth Investors Core Laboratories NV transactions over time
- Total transactions:
- 45
- New positions:
- 1
- Added:
- 22
- Reduced:
- 22
- Held since:
- 2015 Q1
- Held for:
- 45 quarters
- Latest activity:
- 2026 Q1
Fred Martin has been an institutional investor in Core Laboratories NV (CLB) since 2015 Q1. According to 2026 Q1 report, Fred Martin holds 4,937,115 shares with a market value of roughly $82.89M representing 1.70% of their equity portfolio. The fund/company first acquired CLB in 2015 Q1, initially purchasing 345,125 shares. Since the initial investment, Disciplined Growth Investors has made 44 more transactions in this position.
Does Fred Martin still hold CLB?
Yes, Fred Martin continues to hold Core Laboratories NV (CLB). According to their 2026 Q1 report, they maintain a position of 4,937,115 shares valued at approximately $82.89M, representing 1.70% of their equity portfolio.
When did Fred Martin first invest in CLB?
Fred Martin first invested in Core Laboratories NV (CLB) in 2015 Q1 at the reported quarter-end price of $104.49 per share, acquiring 345,125 shares in their initial purchase.
What is Fred Martin's average cost basis for CLB?
Based on historical transaction data, Fred Martin's estimated cost basis for Core Laboratories NV (CLB) is approximately $26.21 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $26.21
- Weighted AVG sell price:
- $19.52
CLB transactions history by Disciplined Growth Investors
45 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.70%
|
4,937,115
|
$16.79
|
$82,894,161
|
-4.45% (-229,799)
|
-0.07%
|
|
2025 Q4
|
1.59%
|
5,166,914
|
$16.03
|
$82,825,631
|
-13.45% (-802,946)
|
-0.23%
|
|
2025 Q3
|
1.34%
|
5,969,860
|
$12.36
|
$73,787,470
|
+9.72% (+528,976)
|
+0.12%
|
|
2025 Q2
|
1.20%
|
5,440,884
|
$11.52
|
$62,678,984
|
-0.93% (-50,838)
|
-0.01%
|
|
2025 Q1
|
1.70%
|
5,491,722
|
$14.99
|
$82,320,913
|
-0.22% (-11,929)
|
-0%
|
|
2024 Q4
|
1.81%
|
5,503,651
|
$17.31
|
$95,268,199
|
-2.65% (-149,940)
|
-0.05%
|
|
2024 Q3
|
1.98%
|
5,653,591
|
$18.53
|
$104,761,041
|
+26.74% (+1,192,871)
|
+0.42%
|
|
2024 Q2
|
1.70%
|
4,460,720
|
$20.29
|
$90,508,009
|
+446.82% (+3,644,963)
|
+1.39%
|
|
2024 Q1
|
0.25%
|
815,757
|
$17.08
|
$13,933,130
|
+8.43% (+63,390)
|
+0.02%
|
|
2023 Q4
|
0.29%
|
752,367
|
$17.66
|
$13,286,801
|
+1.89% (+13,983)
|
+0.01%
|
|
2023 Q3
|
0.42%
|
$24.01
|
-2.74% (-20,808)
|
|||
|
2023 Q2
|
0.40%
|
$23.25
|
-4.56% (-36,292)
|
|||
|
2023 Q1
|
0.45%
|
$22.05
|
-9.69% (-85,333)
|
|||
|
2022 Q4
|
0.46%
|
$20.27
|
-0.98% (-8,744)
|
|||
|
2022 Q3
|
0.33%
|
$13.48
|
+3.29% (+28,348)
|
|||
|
2022 Q2
|
0.46%
|
$19.81
|
+0.64% (+5,482)
|
|||
|
2022 Q1
|
0.59%
|
$31.63
|
+6.23% (+50,185)
|
|||
|
2021 Q4
|
0.36%
|
$22.31
|
+67.24% (+323,871)
|
|||
|
2021 Q3
|
0.26%
|
$27.75
|
+9.92% (+43,482)
|
|||
|
2021 Q2
|
0.33%
|
$38.95
|
+0.14% (+624)
|
|||
|
2021 Q1
|
0.26%
|
$28.79
|
-12.16% (-60,576)
|
|||
|
2020 Q4
|
0.25%
|
$26.51
|
-2.48% (-12,664)
|
|||
|
2020 Q3
|
0.18%
|
$15.26
|
-3.16% (-16,675)
|
|||
|
2020 Q2
|
0.26%
|
$20.32
|
-31.59% (-243,602)
|
|||
|
2020 Q1
|
0.18%
|
$10.34
|
+2.02% (+15,276)
|
|||
|
2019 Q4
|
0.47%
|
$37.67
|
+1.08% (+8,062)
|
|||
|
2019 Q3
|
0.65%
|
$46.62
|
+2.48% (+18,116)
|
|||
|
2019 Q2
|
0.71%
|
$52.28
|
+115.63% (+391,265)
|
|||
|
2019 Q1
|
0.41%
|
$68.93
|
-0.24% (-829)
|
|||
|
2018 Q4
|
0.42%
|
$59.66
|
-2.13% (-7,390)
|
|||
|
2018 Q3
|
0.67%
|
$115.83
|
+4.79% (+15,857)
|
|||
|
2018 Q2
|
0.77%
|
$126.21
|
-1.14% (-3,802)
|
|||
|
2018 Q1
|
0.71%
|
$108.22
|
-2.13% (-7,278)
|
|||
|
2017 Q4
|
0.74%
|
$109.55
|
+0.33% (+1,137)
|
|||
|
2017 Q3
|
0.70%
|
$98.70
|
-0.42% (-1,450)
|
|||
|
2017 Q2
|
0.72%
|
$101.27
|
+0.09% (+305)
|
|||
|
2017 Q1
|
0.88%
|
$115.52
|
-0.33% (-1,133)
|
|||
|
2016 Q4
|
0.94%
|
$120.04
|
+0.31% (+1,050)
|
|||
|
2016 Q3
|
0.91%
|
$112.33
|
-0.57% (-1,975)
|
|||
|
2016 Q2
|
1.07%
|
$123.89
|
+1.53% (+5,175)
|
|||
|
2016 Q1
|
0.97%
|
$112.41
|
-3.04% (-10,625)
|
|||
|
2015 Q4
|
0.96%
|
$108.74
|
-0.69% (-2,425)
|
|||
|
2015 Q3
|
0.90%
|
$99.80
|
+1.14% (+3,975)
|
|||
|
2015 Q2
|
0.96%
|
$114.04
|
+0.77% (+2,650)
|
|||
|
2015 Q1
|
0.85%
|
$104.49
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.